Search Results

Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature

• Authors : Cagdas, Deniz N.; Gucer, Safak; Kale, Gulsev

• Source: Pediatric Nephrology. Sept, 2005, Vol. 20 Issue 9, p1352, 3 p.

Record details

Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard[R]--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever.

• Authors : Amaryan, G.; Astvatsatryan, V.; Gabrielyan, E.

• Source: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology. May, 2003, Vol. 10 Issue 4, p271, 15 p.

Record details

Late diagnosis of severe colchicine intoxication. (Experience And Reason--Briefly Recorded)

• Authors : Gur Guven, Ayfer; Bahat, Elif; Akman, Sema

• Source: Pediatrics. May, 2002, Vol. 109 Issue 5, p971, 3 p.

Record details

Rilonacept for familial Mediterranean fever?

• Source: Nature Reviews Rheumatology. December 1, 2012, Vol. 8 Issue 12

Record details

Research from University of Connecticut, Department of Medicine Provides New Data on Pulmonary Embolism.

• Source: Biotech Week. 2011, pages. 1104

Record details

Colcrys Approved for Acute Gout, Mediterranean Fever; Remedy long used to treat these two inflammatory conditions.

• Source: Consumer Health News (English). 2009.

Record details

Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement

• Authors : Kallinich, Tilmann; Haffner, Dieter; Niehues, Tim

• Source: Pediatrics. Feb, 2007, Vol. 119 Issue 2, p392, 1 p.

Record details

Scientists at Gazi University School of Medicine Publish New Data on Depression

• Source: Mental Health Weekly Digest. June 27, 2011, 30

Record details

FDA Approves Colcrys colchicine, USP for Prevention of Gout Flares

• Source: Pediatrics Week. Nov 7, 2009, p86

Record details

FDA ORDERS HALT TO MARKETING OF UNAPPROVED SINGLE-INGREDIENT ORAL COLCHICINE DRUG COMMONLY USED TO PREVENT GOUT, TREAT GOUT FLARES, AND TREAT FAMILIAL MEDITERRANEAN FEVER (FMF)

• Source: States News Service. Sept 30, 2010

Record details